Peripheral Arterial Disease (PAD) is a multifactorial syndrome that most commonly
affects people over 60 years of age. With the aging of the population, the
prevalence of atherosclerotic disease and its associated adverse outcomes will
increase. It has to be noted that the process of established atherothrombosis is not
limited to a single arterial location, giving it the character of a systemic and
generalized disease. The Reduction of Atherothrombosis for Continued Health
(REACH) registry demonstrated that one out of six patients with (i) PAD, (ii)
cerebrovascular disease, or (iii) coronary artery disease had involvement of one or
two other arterial beds. Importantly, the presence of multiple affected arterial
territories, called polyvascular disease, has been demonstrated to be an
independent predictor of long-term cardiovascular outcome in the general
population.
In response to studies demonstrating the adverse prognosis of
atherosclerotic disease, the need for adequate risk factor stratification and
reduction has emerged. The importance of risk factor reduction in patients with
PAD has resulted in universally recommended atherothrombotic risk factor
reduction, with the objective of decreasing the high incidence of heart disease and
cerebrovascular disease associated with PAD. In patients with PAD scheduled for
vascular surgery, risk factor stratification is directed at the detection of
(a)symptomatic atherosclerotic disease in other vascular beds than the primary
symptomatic arterial location. Early detection of polyvascular atherosclerotic
disease has important consequences for risk factor reduction strategies, including
life-style interventions and medical therapy.
http://repub.eur.nl/res/pub/20709/100915_Kuijk%2C%20Jan-Peter%20van.pdf
http://repub.eur.nl/res/pub/20709/100915_Kuijk%2C%20Jan-Peter%20van.pdf
No comments:
Post a Comment